Send news about your local business to MWBusiness@wickedlocal.com. We’re interested in news about business people, expansions, openings and community involvement by MetroWest businesses and business people. Follow Daily News Business Editor Bob Tremblay on Twitter @Bob Tremblay_MW
MutualOne Foundation supports Natick VNA Meds
The MutualOne Charitable Foundation has awarded $5,000 to the Natick Visiting Nurse Association (VNA) to support the MetroWest Meds program, which gives low-income individuals access to prescription medications at low or no cost. Since the program began in 2004, MetroWest Meds has served more than 5,000 clients and saved more than $7 million in prescription drug costs. This is the sixth consecutive year the MutualOne Foundation has supported MetroWest Meds. The grant was among awards totaling $128,068 in the foundation’s most recent round of funding. Established in 1998 as the philanthropic arm of MutualOne Bank, the Framingham-based foundation has since donated more thanr $4.3 million to charitable, educational and civic initiatives designed to improve and enrich the quality of life in Framingham, Natick and surrounding communities.
Waltham’s Carbon Black announces study results
Carbon Black Inc., a Waltham-based company focused on next-generation endpoint security delivered via the cloud, recently announced the results of a new Forrester Consulting study, “The Total Economic Impact Of The CB Predictive Security Cloud.” In the study, Forrester found that participating organizations that use the CB Predictive Security Cloud experienced a return on investment of up to 261 percent over three years. The study also found that participating organizations who replaced traditional endpoint security with the PSC can realize significant business benefits and cost savings. Customers Forrester interviewed said they selected Carbon Black for its improved protection, visibility and the ability to act quickly and simplified operations.
Waltham’s Entasis reports successful FDA meeting
Entasis Therapeutics Holdings Inc., a Waltham-based clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, recently announced a successful end-of-phase 2 meeting with the U.S. Food and Drug Administration regarding ETX2514SUL for the treatment of patients with pneumonia and bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii. A Gram-negative bacterium causing severe infections, A. baummanii is associated with high mortality, rapidly increasing rates of antibiotic resistance, growing significance as a hospital-acquired infection and limited treatment options. Following this meeting, Entasis remains on track to initiate its phase 3 clinical trial for ETX2514SUL in the first quarter of 2019.
Framingham’s Arch Therapeutics to present at BIO
Arch Therapeutics Inc., a Framingham-based developer of liquid, gel and solid hemostatic and wound care devices, will be featured as a presenting company at the 2019 BIO CEO & Investor Conference. The conference takes place from Feb. 11-12 at the New York Marriott Marquis in New York City. Dr. Terrence W. Norchi, the company’s CEO, is scheduled to provide a corporate update at 2:15 p.m. Feb. 11 and meet with investors who are registered to attend the conference. Investors interested in attending the conference can go to https://www.bio.org/events/bio-ceo-investor-conference/general-registration. To access the live webcast: http://www.veracast.com/webcasts/bio/ceoinvestor2019/33121486228.cfm. The presentation will be available for download at https://www.archtherapeutics.com.
Concord’s ProcessUnity updates its SIG support
ProcessUnity, a Concord-based provider of cloud-based applications for risk management, has updated its support for the Shared Assessments Standard Information Gathering (“SIG”) questionnaire to include the 2019 version. Seamlessly incorporating the SIG into ProcessUnity’s Vendor Cloud application increases speed, consistency and efficiency in Vendor Risk Management assessments for cybersecurity, IT risk, privacy, data security and business resiliency, according to the company. Shared Assessments is a member-driven, industry-standard body with tools and best practices that help organizations manage the full lifecycle of a third-party relationship, from planning for third party engagement, to due diligence and vendor selection, contract negotiations, ongoing and continuous monitoring and termination. The SIG questionnaire provides an inventory of industry standard questions for the remote assessment process that allows an organization to scope initial assessment information regarding a service provider’s controls. For more information, visit www.processunity.com or visit the ProcessUnity booth at the 12th annual Shared Assessments Summit on April 10-11 in Arlington, Virginia.